文献速递心脑血管急症复苏、休克与脓毒症重症综合管理与镇静镇痛

重症新型冠状病毒肺炎患者心血管结局的经验

Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019.
PubMed 文献 · Crit Care Explor · 2020-12-03
一句话结论单中心回顾性队列显示,重症新型冠状病毒肺炎患者肌钙蛋白升高者占84.03%,且肌钙蛋白升高程度越高、出现心律失常、肺源性心脏病或休克者死亡风险增加(P<0.001)。

该研究为回顾性队列研究,纳入美国亚特兰大一家学术医疗中心3家医院6个专门收治新型冠状病毒肺炎的ICU中的288例患者。主要心血管并发症发生率:肌钙蛋白升高242例(84.03%)、心律失常70例(24.31%)、休克190例(65.97%)、ST段抬高型心肌梗死4例(1.39%)、肺源性心脏病8例(2.78%),死亡86例(29.9%)。肌钙蛋白升高程度越大(P<0.001)以及发生心律失常(P<0.001)、肺源性心脏病(P<0.001)和休克(P<0.001)的患者死亡风险增加。作者所在机构的新型冠状病毒肺炎心脏病学小组委员会基于这些数据提出了心血管并发症的诊断和管理建议,作为床旁资源供新近诊治此类患者的医务人员参考。

要点

  • 288例ICU新型冠状病毒肺炎患者中,肌钙蛋白升高242例(84.03%),休克190例(65.97%),心律失常70例(24.31%),死亡86例(29.9%)。
  • 肌钙蛋白升高程度越大,死亡风险越高(P<0.001);发生心律失常、肺源性心脏病或休克的患者死亡风险亦增加(P<0.001)。
  • ST段抬高型心肌梗死4例(1.39%),肺源性心脏病8例(2.78%),提示重症患者需警惕这些心血管并发症。
  • 作者所在机构的心脏病学小组委员会提出了针对新型冠状病毒肺炎心血管并发症的诊断和管理建议,供床旁参考。

适用人群与场景

  • 入住美国亚特兰大一家学术医疗中心3家医院6个专门收治新型冠状病毒肺炎的ICU的患者。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入288例入住ICU的新型冠状病毒肺炎患者。
  • 死亡86例(29.9%),肌钙蛋白升高242例(84.03%),心律失常70例(24.31%),ST段抬高型心肌梗死4例(1.39%),肺源性心脏病8例(2.78%),休克190例(65.97%)。
  • 肌钙蛋白升高程度越大,死亡风险增加(P<0.001);发生心律失常(P<0.001)、肺源性心脏病(P<0.001)和休克(P<0.001)的患者死亡风险增加。
  • 作者所在机构的新型冠状病毒肺炎心脏病学小组委员会基于病例提出了心血管并发症的诊断和管理建议。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者所在机构的心脏病学小组委员会提出的建议旨在为诊治新型冠状病毒肺炎心血管并发症提供床旁资源,作者认为这些建议可增加对潜在心血管损伤的认识并突出诊断和管理建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Coronavirus disease 2019 is associated with high mortality rates and multiple organ damage. There is increasing evidence that these patients are at risk for various cardiovascular insults; however, there are currently no guidelines for the diagnosis and management of such cardiovascular complications in patients with coronavirus disease 2019. We share data and recommendations from a multidisciplinary team to highlight our institution's clinical experiences and guidelines for managing cardiovascular complications of coronavirus disease 2019.

DESIGN SETTING AND PATIENTS: This was a retrospective cohort study of patients admitted to one of six ICUs dedicated to the care of patients with coronavirus disease 2019 located in three hospitals within one academic medical center in Atlanta, Georgia.

MEASUREMENTS/INTERVENTIONS: Chart review was conducted for sociodemographic, laboratory, and clinical data. Rates of specific cardiovascular complications were assessed, and data were analyzed using a chi-square or Wilcoxon rank-sum test for categorical and continuous variables. Additionally, certain cases are presented to demonstrate the sub committee's recommendations.

MAIN RESULTS: Two-hundred eighty-eight patients were admitted to the ICU with coronavirus disease 2019. Of these, 86 died (29.9%), 242 (84.03%) had troponin elevation, 70 (24.31%) had dysrhythmias, four (1.39%) had ST-elevation myocardial infarction, eight (2.78%) developed cor pulmonale, and 190 (65.97%) with shock. There was increased mortality risk in patients with greater degrees of troponin elevation (p < 0.001) and with the development of arrhythmias (p < 0.001), cor pulmonale (p < 0.001), and shock (p < 0.001).

CONCLUSIONS: While there are guidelines for the diagnosis and management of pulmonary complications of coronavirus disease 2019, there needs to be more information regarding the management of cardiovascular complications as well. These recommendations garnered from the coronavirus disease 2019 cardiology subcommittee from our institution will add to the existing knowledge of these potential cardiovascular insults as well as highlight suggestions for the diagnosis and management of the range of cardiovascular complications of coronavirus disease 2019. Additionally, with the spread of coronavirus disease 2019, our case-based recommendations provide a bedside resource for providers newly caring for patients with coronavirus disease 2019.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Connor-Schuler R, Wong AI, Shah A, et al. Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Explor. 2020. PMID: 33294847. doi:10.1097/CCE.0000000000000288

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。